News
Moderna’s COVID-19 vaccine shows positive results in phase 1 clinical trials
“With these positive interim Phase 1 data and the positive data in the mouse challenge model, the Moderna team continues to focus on moving as fast as safely possible to start our pivotal Phase 3 study in July and, if successful, file a BLA,” said Dr Stéphane Bancel, CEO, Moderna.
Biocon Biologics gets EU approval for its Bangalore manufacturing units
These facilities are used for the manufacture of DS and DP for Biosimilars: Bevacizumab, Trastuzumab, Pegfilgrastim and secondary packaging of Insulin Glargine for EU markets, and were inspected in March 2020.
View: How to test Covid-19 rationally
Datta is chief scientific officer, Bugworks Research, Bengaluru, and Ghosh is professor of mathematics, Indian Institute of Science Bangalore
ABLE & Biocon chief Kiran Mazumdar-Shaw to head biotech innovation council NBRIC
The National Biomedical Resources Indigenization Consortium(NBRIC) aims to make India self sufficient in manufacturing critical vaccines, diagnostics, reagents and therapeutics to tackle ongoing pandemic like COVID-19 and other future pandemics.
voice for BT and BEST 2026
